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Summary.-We have determined that when an extract of human brain is pre-
incubated with lymphocytes its subsequent capacity to inhibit the electrophoretic
mobility oftanned and stabilized erythrocytes is much reduced. There is a differential
effect, however, as the observed reduction is from73% inhibition to 35% when the
pre-incubation is with lymphocytes from patients with malignant disease, but from
73% to 10% when it is with lymphocytes from normal controls. These values were
obtained at a brain extract concentration of 333 I&g/ml, with 5x 106 lymphocytes, a
pre-incubation time of 18-24 h, and a temperature of 27°C, which are the optimum
conditions determined for differentiation between cancer patients and normal
subjects. In a series of73 subjects tested by this method43/51 cancer patients gave an
unequivocal "positive" value, 22/22 normal controls gave a "negative" value, with no
false positives.
THE macrophage electrophoretic mobi-
lity test (MEM) was first described as a
method for the detection of malignant
disease by Field & Caspary (1970) and
Caspary & Field (1971), and since then
workers in a number of laboratories have
attempted, with varying success, to repro-
duce their results. Pritchard et al. (1972,
1973) reported confirmation and also im-
proved methodology with the MOD-MEM
test. Goldstone et al. (1973) reported veri-
fication of the test, but in a subsequent
publication (Lewkonia et al., 1974) re-
ported poor separation between the re-
sponses of those with malignant disease
and those without. Preece & Light (1974)
have described results verifying the test.
Rawlins et al. (1976), while agreeing with
the general conclusions ofField & Caspary
(1970), had some reservations regarding
the numbers of false positives and false
negatives in their results. However, others
(Crozier etal., 1976; Arvilommi etal., 1977;
Forrester et al., 1977) have been unable to
obtain reproducible differences in response
between cancer patients and normal con-
trols, in spite of a systematic approach to
the difficulties inherent in the test. Thus,
as certain groups ofworkers have beenable
to reproduce the results ofField & Caspary
(1970) while others, employing equal care
and attention to detail, have been unable
to do so, the experimental problems ofthe
MEM test have been the subject of much
discussion (see Bagshawe, 1977, and Moore
& Lajtha, 1977). Clearly the test is ex-
tremely sensitive to the experimental con-
ditions employed, especially with regard
to the peritoneal exudates obtained from
the guinea-pigs, and furthermore, macro-
phages are chosen for mobility measure-
ment according to several relatively sub-
jective criteria. Naturally such a test is
difficult to reproduce successfully, and
lends itself to many differences of opinion
as to reasons for success or failure. The
question of the application of the MEM
test to the clinical diagnosis of cancer is
also still largely unresolved, since here also
there are many differences ofopinion as to
the reproducibility and reliability of the
test (see Pritchard et al., 1976; Rawlins etJ. E. D. DYSON AND P. J. CORBETT
al., 1976; and review by Moore & Lajtha,
1977).
We also have attempted to use the MEM
test as a method for detecting the presence
of malignant disease, but with only mar-
ginal success. A serious problem we have
encountered is that, over extendedperiods,
guinea-pigs from our colony have yielded
peritoneal exudates in which a large frac-
tion of the macrophages have an electro-
phoretic mobility 10 to 15% lower than
"normal". Such exudates are unresponsive
in the MEM test and this, combined with
the other difficulties involved in the use of
macrophages, suggested that a search for
some other cell to serve as an indicator cell
would be appropriate at this stage. Thus
when Porzsolt et at. (1975) described the
use oftanned and stabilized sheep erythro-
cytes in the MEM test, it seemed worth
while to attempt to reproduce theirresults,
althoughinfact theirreport suggestedthat
their method had a different experimental
basis than the MEM test.
We report here our initial results em-
ploying tanned and stabilized sheep ery-
throcytes, and the effect of the various
parameters that have been found to
influence the results of the test.
MATERIALS AND METHODS
Preparation of lymphocytes.-Blood was
obtained from patients with known malignant
disease attending Cookridge Hospital, and
from healthy hospital and laboratory staff.
Collection of 10 or 20 ml samples was by
venepuncture using plastic syringes (Sabre-
Gillette Surgical, Isleworth); the blood was
then transferred to glass universal containers
(siliconized with Repelcote-Hopkin and
Williams) containing 3 layers of glass beads
(2.5-3.5 mm diam.-Hopkin and Williams)
and defibrinated by inversion. The defibri-
nated blood was carefully layered on to 8 ml
of Ficoll-Paque (Pharmacia (G.B.) Ltd.,
London) in fresh universal containers and
centrifuged at 500 g max. for 15 min. The
lymphocytes were collected by pipette from
the Ficoll-Paque/serum interface, washed x 3
with Hanks' balanced salt solution (HBSS)
and finally suspended in Eagle's Basal Me-
dium (BEM) at a concentration of 5 x 106
cells/ml. Cell counts were carried out micro-
scopically with a Neubauer haemocytometer.
Monocyte contamination of the lymphocyte
preparations was estimated to be from 0 to
1% with one exception (prostate with skin
involvement), where it was estimated to be
10%.
Proteinpreparations.-A brain extract (BE)
was prepared from human brain according to
the method of Caspary & Field (1965), omit-
ting the ammonium sulphate fractionation
step, freeze-dried, dissolved in HBSS, dia-
lysed x 3 against HBSS, adjusted to a pro-
tein concentration of 10 mg/ml, and stored
at -20°C. When injected intradermally into
guinea-pigs, together with Freund's complete
adjuvant (Gibco-Biocult Ltd, Paisley, Scot-
land), 200 jig of this preparation resulted in
paralysis ofthehindlegs within 15 to 17 days,
and death after 17 to 21 days; quantities
smaller thail 200 Ktg were uncertain in their
action. A highly purified preparation of mye-
lin basic protein (MBP) was also isolated from
human brain according to a method devised
by Dr J. P. Dickinson (personal communica-
tion). This was prepared as follows: myelin
was isolated from the white matter of human
brain by sucrose-gradient centrifugation, and
defatted with acetone, according to the
method of Eylar et al. (1969). The defatted
myelin was extracted for 12 h with dilute
HCI, pH 1-5-2-0, and the solid residue re-
moved by centrifugation and discarded. The
supernatant was passed through DEAE
cellulose (Whatman) at neutral pH, the MBP
remaining in the filtrate under these condi-
tions. The filtrate was adjusted to 0-2 M in
Na acetate and passed through a column
(2.5 x30 cm) ofCM cellulose (Whatman) equi-
librated with 0-2 M Na acetate. A Na acetate
gradient of 0-2 to 1-0 M was applied to the
column, the MBP being eluted at an Na
acetate concentration of0 5 to 0-7 M. Injection
of 5 ,tg of this preparation into guinea-pigs
resulted in paralysis of the hind legs, in-
continence and death withini 14 to 18 days.
Protein concentrations were determined by
the biuret method of Gornall et al. (1949) vs
a serum-albumin standard.
Indicator cells.-Sheeperythrocytes, tanned
and stabilized with sulphosalicylic acid, were
obtained as a lyophilized preparation from
Behring-Werke A.G., Marburg-Lahn, West
Germany. An aliquot was freshly prepared
for use each day by suspension in HBSS,
washing x 3 with HBSS, and adjusting to a
final concentration of 100 x 106 cells/ml.
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Preparation of solutions.All solutions
were prepared with double-glass-distilled
water and "Analar" reagents (BDH Ltd,
Liverpool). HBSS and BEM were prepared
in the laboratory without phenol red, and
-were adjusted to a pH of 7.30 wAith sterile 4%
bicarbonate solution immediately before use.
BEM was prepared with amino acid and
vitamin supplements (Flow Laboratories,
Irvine, Scotland). The conductivity of the
BEM wN-as routinely checked and determined
to be 1-596+0-014 x 10-2 mho/cm at 25°C
(Model MCI Mk V, Electronic Instruments
Ltd, Chertsey).
Electrophoretic measurements. - Except
where otherwise stated, 5 x 106 lymphocytes
were incubated, in a screw-top 8 ml tube,
with 1 mg of BE in a final volume of 3 ml,
and at a temperature of 270±0050C. The
period of this pre-incubation is noted in the
appropriate Figures. On termination of pre-
incubation the tubes were centrifuged (300 g
max. 10 min) and the supernatants trans-
ferred to a fresh tube containing 25 x 106
tanned and stabilized sheep erythrocytes in
0-25 ml of HBSS, and incubated at 27°C for
60 min before electrophoretic mobility
neasurements.
The electrophoretic mobility of the ery-
throcytes was determined in a cytophero-
meter (Zeiss, Oberkochen/Wuertt, West Ger-
many) -with modified electrode chambers and
Ag/AgCl/KCl electrodes (Cam-Apparatus,
Impington, Cambridge). The solution in the
electrode chambers was 0415 M KC1 to avoid
the problems associated with a more concen-
trated solution diffusing into the sample
chamber. The stability of the instrument was
much enhanced by the substitution of the
modified chambers for those originally fitted,
and previous problems with vibration were
virtually eliminated.
All measurements were carried out at a
potential difference of 155 V and current of
9 mA, and a temperature of 27+0 005°C. The
time for each of 15 to 20 cells from each
sample to cross one square of the microscope
grid was determined, each cell being timed in
both directions of the field (1 grid square=
23-54 /tm). Any measurements in which the
difference in timings for the two directions of
the field was greater than 150 werediscarded.
The image ofthe front stationary plane ofthe
cell, together with that ofthe microscope grid,
was displayed on a T.V. monitor for mobility
measurements; cells in focus in the stationary
layer were chosen at random for measure-
ment. The set of paired timings for each
sample were averaged, and a percentage
calculated as:
100 (T2 -Ti) o slowing
where T1 is the average time for a sample of
erythrocytes without addition, and T2 is the
average time for a sample of erythrocytes
with addition of BE, with or without pre-
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FIG. 1. Effect of BE concentration on the
electrophoretic mobility of tanned erythro-
cytes (EME) afterpre-incubation ofBE with
or without lymphocytes. (a) 4h pre-
incubation. (b) 20h pre-incubation.
(A *A) pre-incubated without lympho-
cytes. (0* 0) pre-incubated with lympho-
cytes from patients with malignant disease.
(0- 0) pre-incubated with lymphocytes
from normal controls. Other conditions as
stated in text. Each point shown is the
average of triplicate determinations using
3 different lymphocyte donors. Curves
fitted visually to experimental points.
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FIG. 2.-Decrease in capacity ofBE to reduce
EME when pre-incubated with lympho-
cytes; effect of lymphocyte number.
Lymphocytes from patients with malignant
disease: (0-0) 4h pre-incubation.
(Q 0) 20h pre-incubation. Lympho-
cytes from normal controls: (A-A) 4h
pre-incubation. (A-A) 20h pre-incuba-
tion. Other conditions as stated in text.
Each point shown average of duplicate
determinations using different lympho-
cyte donors. Curves fitted visually to
experimental points.
incubation with lymphocytes. In order to
avoid, as far as possible, operator bias of the
results, the following coding procedure was
adopted: in the case ofthe data ofFigs. 1 and
2 the operator was aware ofthe source of the
lymphocytes used in a particular experiment,
but the tubes were coded so that the treat-
ment protocol of the individual samples was
not known to the operator when the measure-
ments were carried out. For the data pre-
sented in Fig. 3 and the Table, several blood
samples were taken from cancer patients and
normal controls during a morning, and were
coded before being passed to the laboratory.
Thus the operator was not aware of the cate-
gory to which the lymphocyte donor belonged
when the measurements were carried out.
RESULTS
Effect of BE on erythrocyte mobility
The electrophoretic mobility of fresh
sheep erythrocytes is 1-14 gzm/sec/V.cm
(Seaman & Uhlenbruck, 1963); this com-
pares with the value determined for the
tanned and stabilized cells in the prepara-
tionusedinthisstudyof1-20+0-03,um/sec/
V. cm.
In order to provide a baseline for sub-
sequent measurements ofthe effect ofpre-
incubation of BE with lymphocytes, the
effect of BE alone on the electrophoretic
0 z
Z0
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FIG. 3.-Decrease in capacity ofBE to reduce
EME when pre-incubated with lympho-
cytes; effect of time of pre-incubation.
(A-A*) pre-incubated without lympho-
cytes. (0-0) pre-incubated with lympho-
cytes from patients with malignant disease.
(0-0) pre-incubated with lymphocytes
from normal controls. Each point repre-
sents a determination on one subject.
Other conditions as stated in text. Top
curve fitted by regression analysis. Two
bottom curves: fitted visually to experi-
mental points up to 8 h; above 8 h but
excluding 48 h, fitted by regression analy-
S1$.
mobility of the erythrocytes (EME) used
was determined. When the EME was
measured after incubation for 1 h at 27°C
with different concentrations of BE, re-
sults essentially identical to those shown
in Figs. IA and lB (top lines) were ob-
tained. Thus, in contrast to macrophages,
tanned and stabilized erythrocytes are
slowed even by low levels (30 ,tg/ml) of
BE.
Effect ofpre-incubation of BE with
lymphocytes
To determine the effect of pre-incuba-
tion of the BE with lymphocytes, a series
of samples was prepared containing vary-
ing amounts of BE together with lympho-
cytesfrom eithernormal subjects or cancer
patients; controls contained BEinmedium
404EFFECT OF LYMPHOCYTE SUPERNATANTS ON ERYTHROCYTES
TABLE.-Residual
tanned erythrocyI
patients with ml
showing results r
and also averageJ
tested
Diagnosis*
Patients with malignant
disease:
Breast
Bladder
Parotid (right)
Prostate (skin
involvement)
Anus (anal verge)
Breast
Cervix
Larynx
Bladder
Bronchus
Tongue
Prostate
Rectum
Colon
Bladder
Ovary
Bronchus (bony mets.)
Rectum
Bladder
Penist
Rectum+ bronchus
Prostate
Teratomat
Urethra
Seminoma
Breast
Normal controls
14 male, 8 female
ages 22 to 50
* Subjects for testin
patients with known i
prescription clinics at
radiotherapy.
t 16-24 h pre-incub
lymphocytes; other cox
t After surgery, poss
only. After pre-inc
samples were cei
natants and contr4
containing an aliq
cubated at 27°C fo:
termined. In all c
the supernatants
taining lymphocyl
duction of the EM]
whose slowing cape
changed by pre-in
IB). This loss of
percentage slowing of creased with time of pre-incubation, so
tes for the series of 51 that supernatants from samples pre-
alignant disease tested, incubated for 20 h with lymphocytes from
elated to site of disease, normal subjects had lost essentially all
for the 22 normal subjects capacity to reduce EME. Moreover, for
comparable periods of pre-incubation,
Number Percentage supernatants from samples containing
tested slowingt lymphocytes from normal subjects had
lost considerably more slowing capacity
1 68-67 than had those containing lymphocytes
1 58 69 from cancer patients (compare centre and
bottom lines, Figs. IA and iB). On no occa-
1 39607 sion, even with BE concentrations (30 pg/
12 36205±7 39 ml) and times of pre-incubation (1 h) com- 9 38 36±5 09 parable with the MEM test, was it found
1 38722 that supernatants from tubes containing 1 37-63
7 36 74+3 77 BE plus lymphocytes from cancer patients 1 31 71 caused EME reduction greater than that
1 28860 caused by an equal concentration of BE
1 27-13 alone, pre-incubated withoutlymphocytes.
1 23 87 On the contrary, the reduction in the
1 2171 EME could be attributed in all cases to the
1 19-53 BE alone, and the effect of pre-incubation
1 16603 of the BE with lymphocytes was to cause
1 15-53 a reduction in the slowing capacity of the
1 13197 BE. These experiments thus suggest that
1 13 64 either the erythrocytes used were in- 1 9.34
1 5 71 herently incapable of responding to slow-
1 5-45 ing factor released by sensitized lympho-
51 cytes on stimulation by the BE, or, alter-
natively, that the erythrocytes were
saturated by the BE and therefore ren- 22 9 65
r 303 dered incapable of responding. Super-
mg selected at random from natants from lymphocytes incubated with-
malignant disease attending
Cookridge Hospital before out BE were also tested, but were found
to have essentially no effect on the EME, nadtion ofsiBnEwth 5tx 10 no increase or decrease being observed,
iibly no tumour present. irrespective of the lymphocyte source.
The experiments described above de-
vubation for 4-20 h the monstrated, however, a differential effect
ntrifuged, and super- which might be used to identify subjects
ols transferred to tubes with malignancy, insofar as all measure-
uot of erythrocytes, in- ments pointed to the fact that the loss of
r 1 h, and the EME de- slowing capacity by the BE was greater
ases it was found that when the lymphocytes were from normal
from those tubes con- subjects than when the lymphocytes were
tes caused a lesser re- from cancer patients. As further results
E than did the controls, were accumulated it became apparent
Lcitywas essentially un- that the slowing capacity (residual slow-
cubation (Figs. IA and ing capacity) of the BE which remained
slowing capacity in- after pre-incubation with lymphocytes
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from either cancer patients or normal sub-
jects was dependent on the BE concentra-
tion, lymphocyte number, temperature,
and time of pre-incubation. In order,
therefore, to be able to employ optimal
conditions for the greatest difference be-
tween results for normal subjects and for
cancer patients, the influence ofthesepara-
meters would have to be investigated, and
the following sections describe the ex-
perimental conditions that were deter-
mined for use in the test.
Effect ofpurified MBP
The effect of substituting a highly puri-
fied preparation of MBP for the BE was
also determined. At equal concentrations,
the MBP was found to possess ~30 of
the inhibitory capacity of the BE; how-
ever, in contrast to the crude BE, this in-
hibitory capacity was found to be stable
and was not lost in pre-incubation with
lymphocytes. In agreement with the re-
sults obtained for the BE, however, no
reduction in the EME was observed which
was not attributable to the MBP alone. At
concentrations comparable to those used
in the MEM test (30 ,ug/ml) the MBP had
little if any effect on the EME, which sug-
gests that, had the erythrocytes used been
capable of responding to slowing factor,
they would have done so under these
conditions.
Effect of BE concentration
The relationship between the BE con-
centration and the inhibition of EME is
shown in detail in Figs. IA and 1B. The
top lines present results for controls pre-
incubated for 4 h (Fig. IA) and 20 h (Fig.
iB) without the addition of lymphocytes.
The centre lines present the results ob-
tained when the pre-incubation wascarried
out with the addition oflymphocytes from
patients with malignant disease, while the
bottom lines present results obtained when
the pre-incubation was with lymphocytes
from normal subjects. The results shown
suggested that a BE concentration of
300-400 /tg/ml would result in optimal
differentiation between the two groups,
and 333 Hg/ml was chosen as representing
a 100 [I aliquot of a 10 mg/ml solution in
a final volume of 3 ml.
It will be noted that as the BE concen-
tration is increased above 400 ,tg/ml the
effect of pre-incubation with lymphocytes
is gradually decreased, and is essentially
lost at a concentration of 1 mg/ml of BE.
Fffect of number of lyrnphocytes
As lymphocytes from patients with
malignant disease were less effective than
those from normal controls in decreasing
the level ofslowing caused by a given con-
centration of BE, it was determined to
what degree the number of lymphocytes
in the pre-incubation mixture influenced
the extent of the reduction. The results
obtained are shown in Fig. 2 for a 4 h and
a 20 h pre-incubation. When BE was pre-
incubated with increasing numbers of
lymphocytes from normal controls it was
found that the slowing capacity ofthe BE
reached its minimum, with about 9%
slowing remaining, when pre-incubated
with 4-5 X 106 lymphocytes, and remained
nearly constant thereafter. In contrast,
when the pre-incubation was with lympho-
cytesfrom patientswithmaiignantdisease,
the decreased level of slowing due to pre-
incubation with 15 x 106 lymphocytes was
still above the value of 9% achieved with
lymphocyte numbers of 5x 106 and above
from normal subjects. However, it is clear
from Fig. 2 that addition of a sufficiently
large number of lymphocytes from cancer
patients will achieve the same decrease in
slowing capacity ofthe BE as that reached
by lymphocytes from normal controls.
Fig. 2 shows that the maximum differ-
ence between the two groups is close to the
point where pre-incubation of the BE is
with 5 x 106 lymphocytes, and this value
was therefore chosen for routine measure-
ments. This choice was also influenced by
the fact that the number of lymphocytes
isolated from 1Oml blood samples from
patients with malignant disease is usually
between 5 and lOx 106.
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Effect ofpH
Within the pH range 5-5-8-5 no change
was observed in the inhibition of the
mobility of sheep erythrocytes by BE,
or the effectiveness of lymphocytes of
either group in reducing the level of this
inhibition on pre-incubation with the BE.
Effect of time ofpr-e-inctbation
As shown in Figs. 1 and 2, increased
time of pre-incubation of the BE with
lymphocytes resulted in increased loss
ofits capacity to reduce the EME. A more
detailed study of the time-dependency of
the effect ofpre-incubation ofthe BE with
lymphocytes is presented in Fig. 3. This
shows that the pre-incubation of BE for
up to 26 h without addition of lympho-
cytes, but under otherwise identical con-
ditions, resulted in an average decrease of
30o in the slowing capacity of the BE.
With addition of lymphocytes from pa-
tients with malignant disease, and a 16-
24 h pre-incubation, the slowing capacity
of the BE was decreased from 73% to
,,350o. When lymphocytes from normal
controls were pre-incubated with the BE
for 16-24 h, the slowing capacity of the
BE decreased to ] 000, this representing
about a 2500 greater decrease in slowing
capacity than that observed with pre-
incubation with lymphocytes from cancer
patients.
A number of pre-incubations were also
carried out for 48 h, but no advantage was
found in exceeding 24 h (see Fig. 3). In the
case oflymphocytes from normal subjects,
further decrease in the slowing capacity of
the BE was of the order of a few per cent
when the pre-incubation was prolonged
from 24 to 48 h. With lymphocytes from
cancer patients, a 48 h pre-incubation re-
sulted in a further decrease of 20% in
the slowing ability of the BE, compared
to the 24 h value. As this reduces the dif-
ference in residual slowing capacity be-
tween normal subjects and cancerpatients,
it is obviously disadvantageous.
Although differences in residual slowing
between normal subjects and cancer pa-
tients were generally detectable within
4-6 h, pre-incubations of 16-24 h were
found to be most convenient, and to give
the most clear-cut differences between the
two groups.
Effect of temperature
Temperatures other than 27°C for pre-
incubation were also tested. After pre-
incubation at 37°C for 6 h, the residual
slowing capacity of the BE was found to
be 20%, compared to a value of 50% for a
control aliquot of the same lymphocytes
pre-incubated at 27°C, but otherwise
treated identically. Pre-incubation at 10°C
for 24 h resulted in a residual slowing of
570o, compared to a value of 12% for a
control aliquot pre-incubated at 27°C for
24 h.
It is clearly possible to carry out pre-
incubations for a shorter period at 37°C if
this is preferred, without appreciably
affecting the difference between the two
groups.
Summary of results for subjects tested
The results obtained for the group of
patients with malignant disease and forthe
normal controls are summarized in the
Table, which shows the residual slowing
capacity of the BE associated with a par-
ticular disease site. These values were ob-
tained after 16-24 h pre-incubation of the
BE with lymphocytes under standard
conditions. If values greater than 15% are
arbitrarily taken as positive for malignant
disease, and values less than 15% as nega-
tive, then 46/51 gave a correct positive
reaction, although 3 were only marginally
within this group, 5/51 gave a false nega-
tive reaction, 22/22 gave a correct negative
reaction, writh no false positives.
DISCUSSION
Reference to the data presented here
shows that our results, although differing
in detail, are essentially consistent with
those of Porzsolt et al. (1975), and other
groups (Douwes et al., 1976; Nitzschke et
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al., 1977) who have used tanned and
stabilized erythrocytes, and thus support
their conclusions on the use of these cells
in a test which can apparently detect the
presence of malignancy. Although our
results are consistent with theirs we differ
from these authors in our interpretation
of the phenomenon on which they are
based. They evidently believe that this is
a modification of the MEM test in which
tanned erythrocytes have been substituted
for macrophages. The results we describe
here, however, do not appear to be con-
sistent with the involvement of a lympho-
kine, or, indeed, with the method depend-
ing on an immunological reaction, and we
consider, therefore, that this method is
basically different from the MEM test.
We have been consistently unable to
detect the presence of a slowing factor
with the erythrocyte preparations used,
although with the pure MBP, which was
known to be active in the MEM test, and
which produced little or no slowing of the
erythrocytes at low concentrations (30 ,g/
ml), this should have been possible had
the erythrocytes been capable of respond-
ing. The reduction of the electrophoretic
mobility of the erythrocytes (EME) ap-
pears, therefore, to be attributable only
to the BE, and the effect ofthe incubation
with lymphocytes is to decrease the slow-
ing capacity of the BE. This is essentially
the reverse of the situation in the MEM
test, where much lower concentrations of
BE are used, which do not affect the mobi-
lity of the macrophages, and where slow-
ing is attributed to release of slowing fac-
tor by the lymphocytes on stimulation by
BE. Furthermore, the pure MBP, although
at least 20-fold more potent in inducing
experimental allergic encephalomyelitis in
guinea-pigs than the BE, was much less
effective in slowing erythrocytes, and this
effect was not lost on pre-incubation with
lymphocytes. This supports the view that
the function of the BE is, in this case, not
immunological, and it also suggests that
the method depends on some constituent
ofthe BE other than MBP.
Results have been recently published
by Harlos & Weiss (1978), however, which
suggest that it may be possible to prepare
erythrocytes which respond to slowing
factor. A direct comparison with our re-
sults andwiththose ofPorzsolt etal. (1975)
is however difficult, owing to differing
experimental protocols. Theirresults (Har-
los & Weiss, 1978) suggest that erythro-
cytes prepared according to their method
are considerably less sensitive to slowing
by BE than the preparation used by us,
which may allow response to slowing
factor. A final decision on this point must
awaitthe use in our system oferythrocytes
prepared according to their protocol, al-
though it does appear from the different
time-scales involvedthat we are measuring
2 basically different phenomena.
Examination ofFigs. 1-3 shows that the
decrease in the capacity of the BE to re-
duce EME is dependent on the number of
lymphocytes in the pre-incubation mix-
ture, on the time of pre-incubation, on
temperature, and on theBE concentration.
All these factors are consistent with the
action ofthe lymphocytes being to remove
or destroy some constituent of the crude
BE preparation, this constituent being
responsible for reducing EME of the ery-
throcytes. Absence of this constituent
from the chromatographically pure MBP
preparation would explain the latter's
relative ineffectiveness in slowing erythro-
cytes, as well as the observation that such
slowing power as it has was quite stable
to pre-incubation with lymphocytes. The
method, therefore, depends on the obser-
vation that lymphocytes from normal con-
trols are more effective in removing or
destroying this constituent than are lym-
phocytes from patients with malignant
disease. Thus, with appropriate selection
of BE concentration, lymphocyte number,
and time of pre-incubation, patients with
malignant disease may be identified by the
greater residual slowing action of the BE
after pre-incubation with their lympho-
cytes, when compared with values for
normal controls. The method also ob-
viously requires the use of a relatively
crude BE, at least until the possibility of
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isolating the appropriate constituent has
been explored.
A total of 51 patients with malignant
disease has been tested so far, and the
range of sites of disease within this group
is relatively broad, so that conclusions re-
garding effect of disease site, type of
malignancy and tumour load on the resi-
dual slowing of the BE must necessarily
be limited. In the group of43 patients that
gave positive values for residual slowing
there appears to be no correlation between
the values for residual slowing and tumour
load, as light to heavy tumour loads are
distributed randomly throughout the
range of slowing values. Of the 8 patients
who gave residual slowing values in, or
only marginally above, the range for
normal controls, 2 had undergone surgery
and possibly had no tumour present, the
remaining 6 had light to moderate tumour
loads, and thus do not differ in this respect
from the subjects who gave a positive
result.
A double-blind study involving a larger
number ofsubjects is at present being con-
ducted, in order to assess the usefulness of
the method as a means of determining the
presence ofmalignant disease, and this will
also provide an opportunity for studying
the effect ofthe disease parameters on the
values for residual slowing. The present
series, in which 43/51 subjects with malig-
nant disease gave an unequivocal positive
reaction, does, however, represent a highly
significant separation of results, with a
high probability of correctly assigning a
subject to the correct "malignant" or
"normal" group, with few false-positive
errors.
No technical difficulties have so far been
encountered with the test, and it does not
appear to be sensitive to the experimental
conditions employed, provided normal
care is taken in quantitation. The loss of
slowing capacity ofthe BE is a continuous
process in the presence of lymphocytes,
and is thus time- and temperature-depen-
dent to a greater extent than in the case
of the MEM test, and these factors must
therefore be carefully controlled. The cyto-
pherometer operator is not faced with the
task ofchoosing a particulartypeofmacro-
phage for measurement, as in the MEM
test, but can choose erythrocytes at ran-
dom from those in focus in the stationary
layer. Thus operator judgement in choos-
ing the correct type of macrophage for
measurement is not a factorinthismethod.
The problems of maintaining a guinea-pig
colony and obtaining peritoneal exudates
containing appropriately responsive mac-
rophages are also avoided.
This work was carried out with the sole financial
support ofthe Yorkshire Cancer Research Campaign,
and was directed by Professor C. A. F. Joslin. We
are indebted to Dr Sheila Corbett for blood samples
from her patients and to the Consultant Staff of
Cookridge Hospital for permission to approach their
patients for blood samples; also to Dr J. P. Dickin-
son for help and advice, and for making available his
method for isolating myelin basic protein, and to
Mr Denzil Evans of Hoechst Pharmaceutical Divi-
sion for obtaining and supplying us with tanned and
stabilized sheep erythrocytes from Behring Werke
A.G., Marburg-Lahn, West Germany.
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